-
1
-
-
0021815367
-
Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol
-
Saya FG, Coleman LT, Martinoff JT. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm. 1985; 42:1965-9.
-
(1985)
Am J Hosp Pharm
, vol.42
, pp. 1965-1969
-
-
Saya, F.G.1
Coleman, L.T.2
Martinoff, J.T.3
-
2
-
-
0027517894
-
The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial
-
Raschke RA, Reilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med. 1993; 119:874-81.
-
(1993)
Ann Intern Med
, vol.119
, pp. 874-881
-
-
Raschke, R.A.1
Reilly, B.M.2
Guidry, J.R.3
-
3
-
-
0029825408
-
Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation
-
Shalansky KF, FitzGerald JM, Sunderji R et al. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Pharmacotherapy. 1996; 16:1076-84.
-
(1996)
Pharmacotherapy
, vol.16
, pp. 1076-1084
-
-
Shalansky, K.F.1
FitzGerald, J.M.2
Sunderji, R.3
-
4
-
-
0031469010
-
Reevaluation of a weight-based heparin dosing nomogram: Is institution-specific modification necessary?
-
Schlicht JR, Sunyecz L, Weber RJ et al. Reevaluation of a weight-based heparin dosing nomogram: is institution-specific modification necessary? Ann Pharmacother. 1997; 31:1454-9.
-
(1997)
Ann Pharmacother
, vol.31
, pp. 1454-1459
-
-
Schlicht, J.R.1
Sunyecz, L.2
Weber, R.J.3
-
5
-
-
0031690335
-
Weight-based heparin dosing: Clinical response and resource utilization
-
Lackie CL, Luzier AB, Donovan JA et al. Weight-based heparin dosing: clinical response and resource utilization. Clin Ther. 1998; 20:699-710.
-
(1998)
Clin Ther
, vol.20
, pp. 699-710
-
-
Lackie, C.L.1
Luzier, A.B.2
Donovan, J.A.3
-
6
-
-
0034650447
-
Partnering with nurses to manage heparin therapy with a weight-based protocol
-
Price CK, Colodny L. Partnering with nurses to manage heparin therapy with a weight-based protocol. Am J Health-Syst Pharm. 2000; 57:110-2,115-6.
-
(2000)
Am J Health-Syst Pharm
, vol.57
, Issue.110-112
, pp. 115-116
-
-
Price, C.K.1
Colodny, L.2
-
7
-
-
0034796449
-
An institution-specific heparin titration nomogram: Development, validation, and assessment of compliance
-
Sherman DS, Clarke SH, Lefkowitz JB et al. An institution-specific heparin titration nomogram: development, validation, and assessment of compliance. Pharmacotherapy. 2001; 21:1167-74.
-
(2001)
Pharmacotherapy
, vol.21
, pp. 1167-1174
-
-
Sherman, D.S.1
Clarke, S.H.2
Lefkowitz, J.B.3
-
8
-
-
0032948223
-
Problems with monitoring heparin anticoagulation
-
Bussey HI. Problems with monitoring heparin anticoagulation. Pharmacotherapy. 1999; 19:2-5.
-
(1999)
Pharmacotherapy
, vol.19
, pp. 2-5
-
-
Bussey, H.I.1
-
9
-
-
0032812237
-
Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration
-
Koerber JM, Smythe MA, Begle RL et al. Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration. Pharmacotherapy. 1999; 19:922-31.
-
(1999)
Pharmacotherapy
, vol.19
, pp. 922-931
-
-
Koerber, J.M.1
Smythe, M.A.2
Begle, R.L.3
-
10
-
-
0032744959
-
Heparin monitoring: The confusion continues
-
Smythe MA, Koerber JM. Heparin monitoring: the confusion continues. Pharmacotherapy. 1999; 19:1240-2.
-
(1999)
Pharmacotherapy
, vol.19
, pp. 1240-1242
-
-
Smythe, M.A.1
Koerber, J.M.2
-
11
-
-
33751252564
-
Monitoring unfractionated heparin with the aPTT: Time for a fresh look
-
Eikelboom JW, Hirsh J. Monitoring unfractionated heparin with the aPTT: time for a fresh look. Thromb Haemost. 2006; 96:547-52.
-
(2006)
Thromb Haemost
, vol.96
, pp. 547-552
-
-
Eikelboom, J.W.1
Hirsh, J.2
-
12
-
-
0033059794
-
Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time
-
Rosborough TK. Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time. Pharmacotherapy. 1999; 19:760-6.
-
(1999)
Pharmacotherapy
, vol.19
, pp. 760-766
-
-
Rosborough, T.K.1
-
14
-
-
3543066284
-
I; for the Heparin Consensus Group. Challenges in variation and responsiveness of unfractionated heparin
-
Francis FL, Groce JB III; for the Heparin Consensus Group. Challenges in variation and responsiveness of unfractionated heparin. Pharmacotherapy. 2004; 24(8, pt 2):108S-119S.
-
(2004)
Pharmacotherapy
, vol.24
, Issue.8 PART 2
-
-
Francis, F.L.1
Groce II, J.B.2
-
15
-
-
2942614745
-
Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight
-
Rosborough TK, Shepherd MF. Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight. Pharmacotherapy. 2004; 24:713-9.
-
(2004)
Pharmacotherapy
, vol.24
, pp. 713-719
-
-
Rosborough, T.K.1
Shepherd, M.F.2
-
16
-
-
0031784749
-
In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone
-
Rosborough TK. In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone. Pharmacotherapy. 1998; 18:1217-23.
-
(1998)
Pharmacotherapy
, vol.18
, pp. 1217-1223
-
-
Rosborough, T.K.1
-
17
-
-
0031937523
-
Optimal weight base for a weight-based heparin dosing protocol
-
Yee WP, Norton LL. Optimal weight base for a weight-based heparin dosing protocol. Am J Health-Syst Pharm. 1998; 55:159-62.
-
(1998)
Am J Health-Syst Pharm
, vol.55
, pp. 159-162
-
-
Yee, W.P.1
Norton, L.L.2
-
18
-
-
0035890018
-
Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients
-
Spruill WJ, Wade WE, Huckaby WG et al. Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients. Am J Health-Syst Pharm. 2001; 58:2143-6.
-
(2001)
Am J Health-Syst Pharm
, vol.58
, pp. 2143-2146
-
-
Spruill, W.J.1
Wade, W.E.2
Huckaby, W.G.3
|